quinazolines has been researched along with alprostadil in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devynck, MA; Le Quan Sang, KH; Mazeaud, MM | 1 |
| Etherington, MD; O'Brien, JR; Salmon, GP | 1 |
| Beretz, A; Cazenave, JP; Corre, G; Lanza, F; Stierlé, A | 1 |
| Duchastel, A; Frojmovic, MM; Milton, JG | 1 |
| Currin, RT; Lemasters, JJ; Lichtman, SN; Reinstein, LJ; Thurman, RG; Wang, J | 1 |
| Kroll, K; Schrader, J | 1 |
| Alvarez, R; Kaneko, T; Nadel, JA; Ueki, IF | 1 |
| Chun, KS; Langenbach, R; Lao, HC | 1 |
| Chae, IG; Chun, KS; Kwon, TK; Min, KJ; Woo, SM | 1 |
9 other study(ies) available for quinazolines and alprostadil
| Article | Year |
|---|---|
Platelet cyclic AMP in essential hypertension.
Topics: Adult; Alprostadil; Blood Platelets; Calcium; Cyclic AMP; Female; Fibrinolytic Agents; Humans; Hypertension; Male; Middle Aged; Quinazolines | 1989 |
DN.9693, a phosphodiesterase inhibitor, compared with prostaglandin E1 and prostacyclin in four platelet "function" tests.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Alprostadil; Clot Retraction; Epoprostenol; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Quinazolines | 1988 |
Cyclic nucleotide phosphodiesterase inhibitors prevent aggregation of human platelets by raising cyclic AMP and reducing cytoplasmic free calcium mobilization.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Alprostadil; Aminoquinolines; Blood Platelets; Calcium; Cyclic AMP; Cytoplasm; Humans; Isoquinolines; Phthalazines; Platelet Aggregation; Quercetin; Quinazolines; Quinolines; Quinolones; Tetrahydroisoquinolines | 1987 |
Microscopic measurements of platelet aggregation reveal a low ADP-dependent process distinct from turbidometrically measured aggregation.
Topics: Adenosine Diphosphate; Adult; Alprostadil; Blood Platelets; Dose-Response Relationship, Drug; Edetic Acid; Female; Fibrinolytic Agents; Humans; Kinetics; Male; Nephelometry and Turbidimetry; Platelet Aggregation; Prostaglandins E; Quinazolines | 1983 |
Suppression of lipopolysaccharide-stimulated release of tumor necrosis factor by adenosine: evidence for A2 receptors on rat Kupffer cells.
Topics: Adenosine; Alprostadil; Animals; Bucladesine; Cells, Cultured; Cyclic AMP; Kupffer Cells; Lipopolysaccharides; Nisoldipine; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P1; Triazoles; Tumor Necrosis Factor-alpha; Xanthines | 1994 |
Myocardial adenosine stimulates release of cyclic adenosine monophosphate from capillary endothelial cells in guinea pig heart.
Topics: Adenosine; Adenosine Deaminase; Adenosine Triphosphate; Alprostadil; Animals; Capillaries; Coronary Vessels; Cyclic AMP; Endothelium, Vascular; Guinea Pigs; Myocardium; Oxygen; Procaterol; Quinazolines; Theophylline; Triazoles; Vasodilation | 1993 |
Elevated intracellular cyclic AMP inhibits chemotaxis in human eosinophils.
Topics: Alprostadil; Chemotaxis, Leukocyte; Colforsin; Complement C5a; Cyclic AMP; Eosinophils; Humans; Phosphodiesterase Inhibitors; Platelet Activating Factor; Quinazolines | 1995 |
The prostaglandin E2 receptor, EP2, stimulates keratinocyte proliferation in mouse skin by G protein-dependent and {beta}-arrestin1-dependent signaling pathways.
Topics: Alprostadil; Animals; Arrestins; beta-Arrestins; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Activation; ErbB Receptors; Gefitinib; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; GTP-Binding Proteins; Keratinocytes; Mice; Mitogen-Activated Protein Kinase 3; Multiprotein Complexes; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Quinazolines; Receptors, Prostaglandin E, EP2 Subtype; Signal Transduction; Skin; src-Family Kinases; STAT3 Transcription Factor; Tyrphostins | 2010 |
Silymarin suppresses the PGE2 -induced cell migration through inhibition of EP2 activation; G protein-dependent PKA-CREB and G protein-independent Src-STAT3 signal pathways.
Topics: Alprostadil; Antioxidants; Benzodioxoles; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Movement; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; GTP-Binding Proteins; HCT116 Cells; HT29 Cells; Humans; Integrases; Kidney Neoplasms; Phosphorylation; Prostaglandin Antagonists; Quinazolines; Receptors, Prostaglandin E, EP2 Subtype; RNA Interference; RNA, Small Interfering; Signal Transduction; Silymarin; src-Family Kinases; STAT3 Transcription Factor; Wound Healing; Xanthones | 2015 |